Aurobindo Pharma Ltd has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Piperacillin and Tazobactam for injection.
Piperacillin and Tazobactam for injection are the generic equivalent of Wyeth's Zosyn injection indicated for the treatment of moderate to severe systemic and/or local bacterial infections in which betalactamase producing bacteria are suspected.The approved drugs have a market size of approximately $635 million for the twelve months ending September 2010.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1654.00 |
| Dr. Reddys Lab | 1215.00 |
| Cipla | 1228.50 |
| Zydus Lifesciences | 927.45 |
| Lupin | 2306.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: